GNPX · Genprex, Inc. · Executive Compensation
$2.75
+0.03 (+1.10%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of our recurring losses from operations and the need for additional financing to fund our operating and capital requirements, there is uncertainty regarding our ability to maintain liquidity sufficient to operate our business effectively over the next 12 months, which raises substantial doubt as to our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.70M
Shares
819,709
Volume · Oct 5
151.73K
Avg daily vol (57 sessions)
266.54K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ryan M. Confer | President, Chief Executive Officer, and Chief Financial Officer | $728,871 |
| Mark S. Berger | Chief Medical Officer | $688,604 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mark S. Berger | Chief Medical Officer | $551,715 |
| Ryan M. Confer | President, Chief Executive Officer, and Chief Financial Officer | $541,567 |
| Catherine M. Vaczy | Former Executive Vice President, General Counsel & Chief Strategy Officer | $449,129 |
| J. Rodney Varner | Former President & Chief Executive Officer | $254,739 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| J. Rodney Varner | Former President & Chief Executive Officer | $1,680,958 |
| Mark S. Berger | Chief Medical Officer | $947,107 |
| Catherine M. Vaczy | Former Executive Vice President, General Counsel & Chief Strategy Officer | $933,278 |
| Ryan M. Confer | President, Chief Executive Officer, and Chief Financial Officer | $886,683 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| J. Rodney Varner | President & Chief Executive Officer | $2,532,400 |
| Catherine M. Vaczy | Former Executive Vice President, General Counsel & Chief Strategy Officer | $1,208,360 |
| Ryan M. Confer | Chief Financial Officer | $1,135,942 |
| Mark S. Berger | Chief Medical Officer | $870,735 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| J. Rodney Varner | President & Chief Executive Officer | $2,347,011 |
| Ryan M. Confer | Chief Financial Officer | $1,339,976 |
| Michael T. Redman | Former Executive Vice President & Chief Operating Officer | $1,312,178 |
| Catherine M. Vaczy | Executive Vice President, General Counsel, & Chief Strategy Officer | $1,293,161 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| J. Rodney Varner | President & Chief Executive Officer | $2,113,891 |
| Catherine M. Vaczy | Executive Vice President, General Counsel, & Chief Strategy Officer | $1,292,631 |
| Ryan M. Confer | Chief Financial Officer | $1,216,859 |
| Michael T. Redman | Former Executive Vice President & Chief Operating Officer | $1,114,916 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ryan M. Confer | Class III director | Appointed | 2026-06-18 |
| Jose Antonio Moreno Toscano | Class III director | Appointed | 2026-06-18 |
| William R. Wilson, Jr. | Class II director | Appointed | 2025-08-15 |
| Catherine Vaczy | Executive Vice President, General Counsel and Chief Strategy Officer | Terminated | 2024-06-24 |
| Ryan M. Confer | President, Chief Executive Officer and Chief Financial Officer | Appointed | 2024-06-24 |
| Ryan Confer | Class III director | Appointed | 2024-05-09 |
| Ryan Confer | President and Chief Executive Officer | Appointed | 2024-05-09 |
| Catherine Vaczy | Executive Vice President, General Counsel and Chief Strategy Officer | Resigned | 2024-02-05 |
| Catherine Vaczy | Executive Vice President, General Counsel and Chief Strategy Officer | Terminated | 2024-02-05 |
| Catherine Vaczy | Executive (per Executive Employment Agreement) | Resigned | 2024-02-02 |